Wordt geladen...
Reviving Lonidamine and 6-Diazo-5-oxo-L-norleucine to Be Used in Combination for Metabolic Cancer Therapy
Abnormal metabolism is another cancer hallmark. The two most characterized altered metabolic pathways are high rates of glycolysis and glutaminolysis, which are natural targets for cancer therapy. Currently, a number of newer compounds to block glycolysis and glutaminolysis are being developed; neve...
Bewaard in:
| Gepubliceerd in: | Biomed Res Int |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Hindawi Publishing Corporation
2015
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4575731/ https://ncbi.nlm.nih.gov/pubmed/26425550 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/690492 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|